PRL and Alzheimer disease: Our study clearly indicates that TBMA could reduce the incidence of AD-induced PRL level increases through DRD2 methylation, providing new insights into the epigenetic mechanism of the increased PRL levels caused by chronic AD administration and potential new treatment strategies based on epigenetic regulation.